# Geographic Atrophy and Intravitreal Ranibizumab Injections

> **NCT02372916** · — · UNKNOWN · sponsor: **University Health Network, Toronto** · enrollment: 90 (estimated)

## Conditions studied

- Age-related Macular Degeneration
- Geographic Atrophy

## Interventions

- **DRUG:** Ranibizumab

## Key facts

- **NCT ID:** NCT02372916
- **Lead sponsor:** University Health Network, Toronto
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-11
- **Primary completion:** 2016-11
- **Final completion:** —
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2015-02-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02372916

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02372916, "Geographic Atrophy and Intravitreal Ranibizumab Injections". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02372916. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*